Buy nordette

Including tdm, the direct expenditures were reduced by 10 tdm led to dose reduction with sustained clinical efficacy, which resulted in a 38 % net drug cost reduction.

Potently, these free drug programs are acth program, confined patient program, compassionate care program or medical desperately program, because nordette 28.

Home products entire websites content for existing websites news and content feeds our content sample topic centers sample health news content management sample sites about cs contact us colds and flu email page print page basic information introduction: what to do for colds and flu cover your cough: frequently asked questions common cold overview questions & answers: cold versus flu flu overview the flu focus on the flu research: flu primer flu drugs influenza symptoms, protection, and what to do if you get sick influenza and your child: information for parents myths and facts about the flu vaccine avian influenza viruses pandemic flu versus avian flu: definitions transmission of the avian flu between animals and people latest news child's flu shot helps whole family online 'epidemic' gives clues to bird flu spread new strategy stretches bird flu vaccine flu season milder than in previous seasons limits on social contact helped fight flu pandemic suppressing cytokines won't protect against avian flu search for highly effective bird flu vaccine goes on fda approves first vaccine for avian influenza flu vaccine grown in insect cells called a promising alternative flu vaccine protects children, even without perfect match flu shot cuts kids' infection risk in half advisers endorse bird flu vaccine health officials unveil flu pandemic plan research may lead to better flu vaccines new flu pandemic could kill 62 million people videos the influenza virus: understanding your enemy the threat of bird flu links articles government information products content for existing websites entire websites news and content feeds sample topics alcohol & substance abuse child care colds and flu pregnancy psychological self-tools flu overview niaid influenza, or flu, is a respiratory infection caused by a variety of flu viruses. Thank you all for your patience and innovative planning as we continue to move through the national pill shortage! Since the formulary committee meeting in May, several changes have been made due to drug prices and availability. The following list summarizes the plan for maintaining costs and at the same time having a reasonable selection of OCPs for our clients. Alesse ON 7 Nrodette * Ortho Cyclen * ON 1 + Triphasil * Ortho Tri-Cyclen Lo * Micronor * Plan B * Available for order from formulary We would still like to discontinue Ortho Cyclen in the future as the current shortages subside due to the cost, therefore we do recommend phasing out Ortho Cyclen usage. Reminder: To access Contraceptive Technology Update online: Go to: contraceptiveupdate User name: 1821244 Password: ctu1821244 Continues to be on back order, future availability is uncertain Discontinued In stock exp. 7 05 In stock In stock Discontinued due to manufacturer unavailability Add to formulary, available July `04 In stock In stock. Find the answers you need about over the counter prescription medications, vitamins supplements, nordette side effects.

Home themengebiete alphabetische liste hilfe faq highlights english version erweiterte suche the use of antiepileptic drugs in children with epilepsy – our current status 1 department of pediatrics, veterans general hospital – kaohsiung, kaohsiung city, taiwan objectives: for patients with documented epilepsy, antiepileptic drug aed ; is the mainstay of treatment and ocuflox. Head of Clinical Pharmacology, Clinical Pharmacologist, key collaborator in all areas of clinical pharmacology and pharmacogenetics. Assoc Prof Murray Barclay.

Physician relationship. Leading purchasers of healthcare, including employers and the federal government, continue to push for a free-market healthcare system that would leave patients more responsible for choosing their healthcare providers and services, essentially turning them into healthcare consumers. Further driving this change are the prevalence of medical information on the Internet and the emergence in the medical marketplace of baby boomers, who are more involved in their healthcare than previous generations. Both factors are changing the role and expectations of patients, likely a continuing trend. Like so much involved with the shifting terrain of healthcare, these changes present both a challenge and an opportunity to healthcare providers. As healthcare changes, patients are using the Internet to educate themselves because they need to be involved in their clinical decisions and need to be informed to do so. Patients are increasingly independent, have access to greater and oxybutynin, for example, nordette reviews.

SciClone's overriding strategic goal is to become a worldwide leader in the development and commercialization of immune system enhancers for the treatment of infectious diseases and cancer. In addition to selective outsourcing to reduce development and manufacturing costs, SciClone has focused efforts on generating revenue in emerging markets to fund clinical trial activities in the United States, Europe and Japan. Zadaxin is currently approved in over 30 countries for various antiviral and oncological indications. Through its wholly owned subsidiary, SciClone Pharmaceuticals International Ltd., the company markets Zadaxin in dozens of developing nations and the People's Republic of China. The cash flow generated by these operations has contributed to the funding of the company's late-stage clinical trials in the U.S. and Japan. International sales of Zadaxin totaled $31.7 million in 2003, with close to 90% coming from China. SciClone has retained development and commercialization rights to Zadaxin in the United States but has entered into licensing agreements for the development of Zadaxin in Europe and Japan. Sigma-Tau, a privately held Italian pharmaceutical company, is SciClone's exclusive marketing and development partner for Zadaxin in the European Union EU ; . As part of this agreement, SciClone will provide its US HCV clinical trial data to assist Sigma-Tau in its attempt to secure regulatory approval in the EU for Zadaxin in HCV. In addition, Sigma-Tau intends to seek EU regulatory approval for Zadaxin in other indications and is currently conducting and funding a phase II clinical trial for Zadaxin in combination therapy for malignant melanoma. Under the terms of the agreement, Sigma-Tau agreed to make $3.7 million in payments to SciClone, including a $2.7 million milestone payment paid in Q1 02 and an additional $1 million payment due upon completion of patient enrollment for the U.S. phase III trials. SciClone will also receive revenues based on sales of Zadaxin to Sigma-Tau for distribution in Europe. In 1993, SciClone outlicensed its Japanese rights to Zadaxin to Schering-Plough. Under the agreement, Schering will pay SciClone undisclosed milestone and royalty payments in exchange for the development, registration and marketing rights to Zadaxin in Japan. Although no payments have been recorded to date under this agreement, Schering remains the company's marketing and distribution partner in that territory. STEP 5: Place your mouth on mouthpiece, and tilt your head back slightly after fully exhaling. Hold the inhaler with blue buttons facing sideways, and inhale. Breathe in fast, steadily, and deeply. As the medicine is released, you will feel a sweet taste on your tongue and hear a whirring noise. If you don't, the capsule may be stuck. Just tap on the side of the inhaler and inhale again. Do not press the side buttons again. ; Remove the inhaler from your mouth, and hold your breath for as long as you comfortably can about 10 seconds and prednisolone. Drug Name kelnor 1 35 leena lessina LEVLEN 28 [G] LEVLITE-28 [G] levora-28 LO OVRAL-28 [G] LOESTRIN 24 FE LOESTRIN FE [G] LOESTRIN [G] low-ogestrel lutera microgestin, fe MIRCETTE [G] MODICON [G] mononessa necon NORDETTE-28 [G] NORINYL 1 + 35, 1 + 50 [G] nortrel NUVARING ogestrel ORTHO EVRA ORTHO TRI-CYCLEN [G] ORTHO TRI-CYCLEN LO ORTHO-CEPT [G] ORTHO-CYCLEN [G] ORTHO-NOVUM [G] OVCON FE OVCON-35 OVCON-50 OVRAL-28 [G] PLAN B portia previfem quasense reclipsen SEASONALE [G] SEASONIQUE solia sprintec sronyx TRI-LEVLEN 28 [G] TRI-NORINYL [G] 2007 Express Scripts, Inc. 11 01 2006. For the soul, body and the spirit must be healed for us to achieve complete healing, " said Dr. Okere. The evangelical part of our ministry continues to grow. Some of the patients that come to the mission area only want prayer said over them. For the newer HIMM missionaries this was a new experience. Pastor Okechukwu was there to pray for people while the medical officers continued with their work. The churches in rural areas of Nigeria continue to seek for sister churches in USA who can assist them in training and planting of new churches and protonix.

Drug to DPPC vs. initial concentration of DNa in SS liposomes are shown in Fig. 1.
Manufacturer-cipla alesse-28 levonorgestrel ethnyl-estradiol levora nordette portia seasonale tri-levlen -used to prevent pregnancy or to regulate your menstrual cycle and theo-dur.
You may find it easier to remember to take them if you take nordette after the evening meal or at bedtime.
The picture shows the types and proportions of food, which help make up a balanced healthy diet and ventolin.

CLINIC Service availability at clinic When are services available If special days, can clients obtain contraceptive services on other days as well Are PN's adequately trained? Does clinic offer the following range of methods - Injectables Depo Provera, Nur Isterate ; - Intra-Uterine Device IUD ; - Oral contraceptives COCs eg Triphasil, Nordette, Ovral 28 ; POP eg Microval ; - Condoms - Female and male voluntary surgical contraception sterilisation ; If NO is there a facility to refer clients Is referral system effective ie clients get services they need promptly? Is there a fast line service available for re-supply DATE [ ] Tick appropriate box Daily Special Days Y N Y. Selling and distribution expenses for the third quarter increased by 439% over third quarter 2002 as a direct result of the costs of marketing, including those associated with the striant launch, and the costs of establishing and significantly expanding a dedicated sales force to promote the company's five brands and cimetidine. Although DTC in pre-adolescent children is reputedly more aggressive than in older adolescents, the role of radioiodine 131I ; ablation to any thyroid remnant following total thyroidectomy for small 1cm ; intra-thyroidal primary tumours in children is not known37. This should be discussed in the thyroid MDT with the clinical oncologist for individual cases. Post-operative 131I ablation of residual thyroid tissue reduces local recurrence and, because of its safety and tolerability, is recommended for all children and adolescents with DTC larger than 1cm in diameter27, 35, 38 following total near total thyroidectomy. This regimen allows post-treatment surveillance with thyroglobulin Tg ; measurements and identification and treatment of any metastases with further ablative 131I therapy. Ablative 131I therapy should be performed in a suitably equipped centre which offers open access during therapy, and after full discussion with the family about potential rare, but important, short and longer term side-effects. These are dose-related and the cumulative activity should therefore be kept as low as possible29, 39. The adult recommended dose is 3.7GBq, increasing to 5.5GBq for refractory disease. Doses for children should be calculated as a percentage of the adult dose, based on body weight in comparison to the average adult weight of 70kg. In adolescent girls, pregnancy must be excluded before 131I is given and avoided for at least 6 and preferably 12 months40. SD 6.2, range 62-81 ; for the subjects with PD and 72.5 years SD-6.46, range 63-85 ; for the control subjects. 'The mean height was 1.63 m SD O.OY, range l.49-1.8 ; for the strbjects with PD and 1.64 m SD 0.09, range 1.45-1.72 ; for the control subjects. The Incall body weight was 62.3 kg SD 12.0, range 46-81 ; for the subjects with PD and 65.0 kg SD 12.0, range 49-80 ; for the control subjects. The mean Webster scale3j score was 13.1 SD 2.9, range 8-18 ; for the slrbjects with PD, and their mean score on the STMS was 28.1 SL ; 5.23, range 21-36 ; . In experime111 1, subjects with PD were tested on average 1.0 h o i 0.25, range 0.3-1.5 ; after their midmorning dose of medication, when they were judged by a physical therapist or a neurologist to have an effective response and to be in the "on" phase of the medication cycle and differin.
It's even ok if you know what is causing your headache but you still choose to take medication. Downloaded from archinternmed on July 25, 2007 2000 American Medical Association. All rights reserved and eldepryl and nordette, for instance, nordette contraception.
Like any other medicine, paracetamol must be taken at the right dose and time. Some people find that paracetamol does not seem to work. However, research has shown that these people are often not taking large enough doses or are not taking it often enough. Talk to your doctor about the right dose for you. If your pain is persistent, try taking the recommended dose of paracetamol regularly. Taking paracetamol regularly means taking it according to the clock, ie every 46 hours, not according to your pain levels. Slow-release paracetamol tablets are now available on prescription for people with osteoarthritis. The slow-release tablets only need to be taken three times a day, which is usually easier to fit into a daily routine than four times a day.

Nordette alternative

If, however, your physician would instruct that lotrisone be spread over wide areas, you might have to take periodic tests and feldene.
Pharmacist to say that levora is a generic form of nordette.

If the patient needs assistance in managing the regimen, say, “ you’ ve said that it’ s hard to remember to take so many pills. Our nordette sale canada offers everyday low prices and a wide selection of generic and brand name medicine. I've been breaking out in hives almost every day for the past 7 months. We can't figure out what the problem is, because we've tried changing laundry detergents, watching what I eat, and anything else we can think of. I on Nodette for birth control. Could that be my problem? I've been on Nordstte for about a year and a half, and my problems began last summer. I break out on my lower torso, my hand and a little now on my face. My arms and upper torso usually don't break out. Help! I do not know if Noedette is causing that or not but you are at the point where you need to discontinue all possible suspects so Norde6te should be stopped for a month to see. If that does not improve things then you should see an allergist. If it does improve the breaking out, you will need to switch to a nonhormonal form of birth control. Eczema I curious after reading about Sarah who has been experiencing skin problems. I started taking Alesse about two months ago to stop my heavy periods. About a month later I started breaking out on my arms and hips. I was told it was eczema caused by excessive dry skin something new to me ; . was wondering if it could be a side-effect of the pill. This is not a common side-effect of any pills but it can happen. It may also be due to something else. The only way to know is to discontinue the pills and see if it goes away. If it does, restart the pills and see if it comes back. That way there is not doubt as to whether it is coincidental or caused by the pill Hair loss I have been taking Alesse since April 98. Prior to that I took Loestrin for several years. In November, I began to notice my hair is falling out. The hair has a small root visible; it is not breaking. The loss is uniform, not located on one area of my head. I could run my fingers through my hair and get a handful. Likewise, when I brush my hair I note more than normal amounts in the brush. I do not color, treat, or even blow-dry my hair. I initially thought it was related to intense stress at work, which began in September and ended in December. Then I noticed that after several months, beginning in January, the amount of hair falling out had declined. I was relieved. Now, in February, it has increased again. I really beginning to worry and although my friends don't notice, I can certainly tell a difference. I had thick, long hair that began to look stringy, so I had it cut short. Now, it looks thin again. I have also been taking a diuretic one herbal supplement a day ; to combat the 6-10 pounds of water weight I gain with each cycle. I take St. John's Wort to help with PMS a few capsules a month ; . For ten years, I have taken a multi-vitamin, Vit E, Vit C, and Calcium supplements. I have also had several bouts with sinus infections this winter and have been taking Entex or Duratuss. I also took the Z-Pack and then Biaxin. When not dealing with sinus infections, I take Claritin D for allergies. Because of my worries I have stopped taking all meds and herbal supplements, until I can identify the reason for hair loss. I've been doing a lot of research on.

Nordette for women

Public companies in this business sector have traditionally adopted a relatively low profile and have not attempted to `talk up' their stock in the way that pharmaceutical and biotechnology companies have done. Usually, when this occurs, the investors are beguiled into believing that the fine chemical company is somehow caught up in the glamour and high risk high reward ethos of these `high-tech' stocks. When reality eventually makes an appearance and the good, but not spectacular returns emerge, the investors realise their mistake and sell their shares, creating a sudden rude awakening for the fine chemical company inside the pharmaceutical `Trojan horse'. Without going into unnecessary detail, it can be stated that the essential investments required to produce fine chemicals for the pharmaceutical industry are and ocuflox.
It can be given up to 120 hours after unprotected intercourse The regime consists of two doses taken 12 hours apart, of at least, levonorgestrel 500ug and ethinyl oestradiol 100ug. This can be achieved by using for each dose any of the following regimes: [19]. NordetteTM MicrogynonTM MonofemeTM LevelenTM x4 TriphasilTM TriquelarTM TrifemeTM LogynonTM, ochre yellow tablets x4 last 10 active pills in the pack ; LoetteTM MicrogynonTM 20 Microlevelen TM, x5 Note Microgynon 50TM is not suitable as it does not contain enough levonorgestrel. Because of the high incidence of nausea and vomiting, this regime is usually dispensed with antiemetics. A spare dose is given in case of vomiting. Results of an international pilot study have shown that real-time glucose monitoring helps patients with diabetes to achieve tighter control of their blood glucose levels, a key to managing the disease and minimising long-term complications. The patients with type 1 diabetes who took part in the pilot study used Medtronic's new Guardian RT Continuous Glucose Monitoring System to check their blood glucose levels throughout the day and night. The system is designed to help patients reduce erratic blood glucose fluctuations that can result in diabetes-related complications, including coma, blindness, kidney failure, amputation, impotence and heart disease. During the 10-day pilot study, all 16 participating patients responded to glucose values as well as high and low alerts displayed on the screen of a Guardian RT System to make proactive therapy decisions following a confirmatory finger stick measurement ; for improved diabetes management. Some 94% of the study participants actively used the real-time glucose values and or high or low glucose alerts to control glucose fluctuations: 75% adjusted their insulin delivery, 63% changed their diet, and 31% made lifestyle changes after gleaning insights from real-time continuous glucose monitoring CGM ; . In addition, 81% of patients reported greater satisfaction with their blood glucose control when using the Guardian RT system. No severe hypoglycaemic or hyperglycaemic events were reported. Results of the pilot study, entitled `First Experience Using the Guardian RT Continuous Glucose Monitoring with Real-Time Values and Alerts in Type 1 Diabetes Mellitus Patients; Results of a Pilot Study', were presented at the 65th Annual Scientific Sessions of the American Diabetes Association in San Diego Abstract Number: 393-P ; . Results of the pilot study are preliminary and no definitive conclusions can be made without confirmation from a larger study. A randomised, controlled, multi-centre study is underway using the Guardian RT System in 162 patients with diabetes in Germany, France, Sweden, Italy, the UK, Slovenia and Israel. The Guardian RT System is designed to use a subcutaneous glucose sensor, which records as many as 288 glucose readings per day providing nearly 100 times more information than three daily finger stick readings. The continuous glucose sensor is a tiny electrode that is inserted under the skin using the SenSerter, a small device that makes sensor insertion easy. The sensor measures glucose in the interstitial fluid found between the body's cells, and is typically discarded and replaced after three days of use. Glucose measurements obtained by the sensor are relayed every five minutes from a transmitter to the Guardian RT's monitor, which displays the glucose value on its screen. In addition, alarm thresholds can be preset to alert patients when glucose levels become too high or too low. The alarm feature is designed to provide added reassurance to patients for managing erratic glucose patterns. Medtronic anticipates real-time continuous glucose readings to be a more advanced method for assessing glucose control compared to today's standards of A1c tests and finger stick measurements. By discovering how diet, exercise, medication and lifestyle affect their glucose levels, patients can make more informed treatment decisions to improve their diabetes management. The Guardian RT System is designed so that patients can also download information to a computer and print reports highlighting their glucose patterns for further analysis and discussion with their healthcare providers. For further information contact Joe McGrath, Tel: 0044 1923 205149, Mobile: 0044 7802 160966, Email: joseph grath medtronic. You must have a thorough medical check-up, including a Pap smear and urine test. Tell your doctor if: 1. you have any allergies to: * any other medicines * any other substances, such as foods, preservatives or dyes 2. you smoke Cigarette smoking increases the risk of serious side effects on the heart and blood vessels when taking oral contraceptives. The risk increases with age and with heavy smoking 15 or more cigarettes per day ; , especially in women more than 35 years old. If you take NORDETTE, you should not smoke. If you smoke you are advised to choose another method of contraception. 3. you have any other health problems, especially: * breast lumps, abnormal breast Xray or mammogram * high cholesterol or blood fats * migraine or other headaches * epilepsy * gallbladder or heart disease * diabetes * high blood pressure * varicose veins * depression NORDETTE R ; 28. Premphase X Prempro X 13.4.3 Selective Estrogen Receptor Modulator Evista X 13.5 Progestin Drugs medroxyprogesterone X acetate norethindrone acetate X Crinone X Depo-SubQ Provera X Endometrin Supp X Crinone, Prochieve First-Progesterone X Crinone, Prochieve Vaginal Suppositories Progesterone in Oil PA, SP X Progesterone powder X Prochieve X Prometrium X 13.7 Contraceptives Not covered under all benefit plans, prior authorization required for medical necessity. Any FDA-approved generic or preferred contraceptive is covered. Quantity limit of one per month. Alesse G X aviane or lessina Cyclessa X Any FDA-approved generic or preferred contraceptive Demulen 1 35, Demulen G X zovia 1 35, Kelnor 1 35 1 zovia 1 50 Depo Provera INJ X 150mg Desogen G X Apri, Any FDA-approved generic or preferred contraceptive Estrostep Fe X Apri, Any FDA-approved generic or preferred contraceptive Levlen G X levora or portia Levlite G X aviane or lessina Lo Ovral G X cryselle or low-ogestrel Loestrin G X microgestin Loestrin Fe G X microgestin Fe Lybrel X Any FDA-approved generic or preferred contraceptive Micronor G X camilla or errin Mircette G X kariva Modicon G X necon 0.5 35 Nordette G X levora or portia Norinyl 1 35, G X necon 1 35 Norinyl 1 50 G necon 1 50 Nor-Q-D G X camila or errin Nuvaring QL X Ortho Evra QL X Any FDA-approved generic or preferred contraceptive Ortho Tri-Cyclen, G X trisprintec Ortho Tri-Cyclen Lo X Ortho-Cept G X Apri Ortho-Cyclen G X mononessa or sprintec Ortho-Novum 1 35 G X necon 1 35 Ortho-Novum 1 50 G X necon 1 50 Ortho-Novum 10 11 G X necon 10 11 Ortho-Novum 7 G necon 7 Ovcon 35 Ovcon 35 X necon 0.5 35 chewable tabs Ovcon 50 X ogestrel or zovia 1 50 Ovral G X ogestrel Ovrette X camila or errin Plan B QL X Seasonale subject to 3 X Any FDA-approved generic or copays, mail order or preferred contraceptive retail ; Seasonique subject to 3 X Any FDA-approved generic or copays, mail order or preferred contraceptive retail ; Tri-Levlen G X enpresse or trivora.
Of neutropenia by making the best use of drugs designed to prevent the problem. All of the study participants were starting new chemotherapy treatment plans and were followed for up to four cycles. More than 1, 100 of the patients experienced at least one episode of severe or febrile neutropenia neutropenia accompanied by a fever ; . Two-thirds of these patients developed this severe condition during their first cycle of chemotherapy. Those at highest risk for severe neutropenia were people treated with a number of different anti-cancer drugs, which led to reduced blood cell counts. In contrast, people with the lowest risk had normal measurements of kidney function and normal neutrophil counts before receiving chemotherapy, or they had begun taking drugs aimed at promoting the growth of white blood cells when they started chemotherapy. The findings suggest that people starting chemotherapy should be given drugs that promote the growth of white blood cells with the first treatment cycle to prevent severe neutropenia. PEGFILGRASTIM NEULASTA ; FOR NON-HODGKIN'S LYMPHOMA A drug called pegfilgrastim Neulasta ; works to prevent neutropenia by promoting the growth of infection-fighting white blood cells. Researchers tested two groups of people receiving chemotherapy to see whether the drug was most effective when administered on the last day of the chemotherapy cycle, or 24 hours later. The clinical trial involved nearly 80 people with nonHodgkin's lymphoma NHL ; . NHL is the umbrella term for dozens of cancers that arise in the blood's array of infectionfighting white blood cells, called lymphocytes. Before the study, none of the participants had received chemotherapy. All of the patients were treated with a drug combination called, for example, nordethe side effects. Fig. 1 a The rate of rise of bilirubin over the first 96 h of life may be normal in CND patients but continues to rise to dangerous levels by day of life 5. Using the 75th percentile hour-specific bilirubin [6] as a screening cutoff value for predicting severe jaundice peak bilirubin 17 mg dl ; , all of these CND patients would have been identified for targeted follow-up and the early institution of phototherapy. b In our CND patients the molar ratio of bilirubin to albumin is elevated from 0.37 to 0.6 during the neonatal period, reaches a nadir by age 4 years, and then rises progressively to adulthood at a rate of 0.022 mol: mol year r 0.82 ; . This is due to a progressive 0.82 mg dl year range: 0.68 0.96 mg dl year ; rise of bilirubin unrelated to patient compliance. Based on the chemistry of bilirubin-albumin binding in healthy individuals, we assign the "safe" bilirubin: albumin molar ratio at or below 0.7 in older children and adults denoted by the dashed line ; [8].
Perhaps more appropriately, it might be stated that it is possible that the record contains such medical opinion, if the ALJ considers and accepts the "fill-in-the-blank" form as containing, in conjunction with the narrative report, such a cognizable medical opinion, despite its being un-sworn, it's lack of business medical record status, it's lack of explanatory rationale for it's conclusions, it's lack of factual description of the bases for it's conclusions, it's apparent genesis as a record created in significant part by counsel for litigation purposes, and the multiplicity of potential meanings that one could read into it, particularly where it purports to assess the potential of the "stressors" to cause the same or similar condition in a non-predisposed individual, without distinguishing "objective" conditions from perceived conditions or events. Nonetheless, without more discussion from the ALJ, the blanket assertion that there is "no medical evidence" of such potential appears to be erroneous.